Showing 67,661 - 67,680 results of 125,061 for search '(( 5 ((026 decrease) OR (a decrease)) ) OR ( a ((mean decrease) OR (point decrease)) ))', query time: 1.16s Refine Results
  1. 67661

    Image3_Exome Sequencing Data Analysis and a Case-Control Study in Mexican Population Reveals Lipid Trait Associations of New and Known Genetic Variants in Dyslipidemia-Associated L... by Pedro A. Jurado-Camacho (12571783)

    Published 2022
    “…We used an LD pruning using a 50-kb sliding window size, a 5-kb window step size and a r<sup>2</sup> threshold of 0.1.…”
  2. 67662

    Table1_Exome Sequencing Data Analysis and a Case-Control Study in Mexican Population Reveals Lipid Trait Associations of New and Known Genetic Variants in Dyslipidemia-Associated L... by Pedro A. Jurado-Camacho (12571783)

    Published 2022
    “…We used an LD pruning using a 50-kb sliding window size, a 5-kb window step size and a r<sup>2</sup> threshold of 0.1.…”
  3. 67663

    DataSheet_1_White common bean extract remodels the gut microbiota and ameliorates type 2 diabetes and its complications: A randomized double-blinded placebo-controlled trial.doc by Yuwei Feng (11685320)

    Published 2022
    “…Subjects in Group C were supplemented with 1.5 g of maltodextrin as a placebo. Subjects in Group W took 1.5 g of WCBE half an hour before a meal. …”
  4. 67664

    Table2_Exome Sequencing Data Analysis and a Case-Control Study in Mexican Population Reveals Lipid Trait Associations of New and Known Genetic Variants in Dyslipidemia-Associated L... by Pedro A. Jurado-Camacho (12571783)

    Published 2022
    “…We used an LD pruning using a 50-kb sliding window size, a 5-kb window step size and a r<sup>2</sup> threshold of 0.1.…”
  5. 67665

    Image2_Exome Sequencing Data Analysis and a Case-Control Study in Mexican Population Reveals Lipid Trait Associations of New and Known Genetic Variants in Dyslipidemia-Associated L... by Pedro A. Jurado-Camacho (12571783)

    Published 2022
    “…We used an LD pruning using a 50-kb sliding window size, a 5-kb window step size and a r<sup>2</sup> threshold of 0.1.…”
  6. 67666

    Figure S1 - HOXA13 Is Essential for Placental Vascular Patterning and Labyrinth Endothelial Specification by Carley A. E. Shaut (46429)

    Published 2008
    “…(C–F) <i>Hoxa13</i> homozygous mutants exhibit a decrease in primary vascular branching as early as E11.5 compared to wild-type controls. …”
  7. 67667

    Baseline progression risk for the model in the top part of <b>Table 4</b>, for a non-black participant in the San Francisco Veterans Affairs Medical Center liver studies cohort [17... by Peter Bacchetti (75155)

    Published 2013
    “…<p>(A) Risk of progression at a time step of 1.5 years given no progression at earlier time steps (<i>hazard</i> of progression). …”
  8. 67668

    Scatterplots showing gonadosomatic index GSI (GSI = (testes weight + SDG weight) / body weight*100) related to total length for early and late reproductive season. by A. C. Utne-Palm (834443)

    Published 2015
    “…Early season has significant higher mean than late season and the relative decrease in GSI depending on total length is steeper in early compared to late season (for more details see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0143487#sec008" target="_blank">results</a>). …”
  9. 67669
  10. 67670

    Supplementary file 1_Efficacy and safety of the commercial Chinese polyherbal preparation Liu Shen Wan as an adjunctive treatment for herpes zoster and postherpetic neuralgia: a sy... by Yajing Li (1394572)

    Published 2025
    “…No restrictions on language.</p>Results<p>A total of 21 RCTs (n = 1,478) were included. Meta-analysis demonstrated that LSW plus conventional treatment significantly outperformed conventional treatment alone in shortening vesicle cessation time [MD = −1.44, 95% CI (−1.66, −0.93), p < 0.00001, I<sup>2</sup> = 70%], accelerating scab formation (MD = −1.72, 95% CI (−2.09, −1.35), p < 0.00001, I<sup>2</sup> = 38%), reducing scab shedding time (MD = −2.22, 95% CI (−3.64, −0.80), p = 0.002, I<sup>2</sup> = 36%), decreasing time to pain resolution (MD = −2.46, 95% CI (−3.52, −1.39), p < 0.00001, I<sup>2</sup> = 0%), and shortening pain persistence duration (MD = −1.97, 95% CI (−2.49, −1.46), p < 0.00001, I<sup>2</sup> = 86%). …”
  11. 67671

    Supplementary file 2_Efficacy and safety of the commercial Chinese polyherbal preparation Liu Shen Wan as an adjunctive treatment for herpes zoster and postherpetic neuralgia: a sy... by Yajing Li (1394572)

    Published 2025
    “…No restrictions on language.</p>Results<p>A total of 21 RCTs (n = 1,478) were included. Meta-analysis demonstrated that LSW plus conventional treatment significantly outperformed conventional treatment alone in shortening vesicle cessation time [MD = −1.44, 95% CI (−1.66, −0.93), p < 0.00001, I<sup>2</sup> = 70%], accelerating scab formation (MD = −1.72, 95% CI (−2.09, −1.35), p < 0.00001, I<sup>2</sup> = 38%), reducing scab shedding time (MD = −2.22, 95% CI (−3.64, −0.80), p = 0.002, I<sup>2</sup> = 36%), decreasing time to pain resolution (MD = −2.46, 95% CI (−3.52, −1.39), p < 0.00001, I<sup>2</sup> = 0%), and shortening pain persistence duration (MD = −1.97, 95% CI (−2.49, −1.46), p < 0.00001, I<sup>2</sup> = 86%). …”
  12. 67672

    Data Sheet 1_Efficacy and safety of the commercial Chinese polyherbal preparation Liu Shen Wan as an adjunctive treatment for herpes zoster and postherpetic neuralgia: a systematic... by Yajing Li (1394572)

    Published 2025
    “…No restrictions on language.</p>Results<p>A total of 21 RCTs (n = 1,478) were included. Meta-analysis demonstrated that LSW plus conventional treatment significantly outperformed conventional treatment alone in shortening vesicle cessation time [MD = −1.44, 95% CI (−1.66, −0.93), p < 0.00001, I<sup>2</sup> = 70%], accelerating scab formation (MD = −1.72, 95% CI (−2.09, −1.35), p < 0.00001, I<sup>2</sup> = 38%), reducing scab shedding time (MD = −2.22, 95% CI (−3.64, −0.80), p = 0.002, I<sup>2</sup> = 36%), decreasing time to pain resolution (MD = −2.46, 95% CI (−3.52, −1.39), p < 0.00001, I<sup>2</sup> = 0%), and shortening pain persistence duration (MD = −1.97, 95% CI (−2.49, −1.46), p < 0.00001, I<sup>2</sup> = 86%). …”
  13. 67673

    Impact of 8-MOP concentration (0 ng/ml, 200 ng/ml, or 300 ng/ml) on cellular response after a 2 J/cm<sup>2</sup> UVA dose. by Marie Laulhé (6416483)

    Published 2019
    “…<p>(A) Percentage of Annexin-V+ cells measured daily up to 2 days after irradiation. …”
  14. 67674

    Table 1_Does screening mode matter? A repeated cross-sectional study of computer self-administered vs. clinician-administered screening of youth substance use in pediatric primary... by Chloe Gao (11107228)

    Published 2025
    “…Of the screening responses, 24.6% were from 12–13-year-olds, 29.5% from 14–15-year-olds, 28.7% from 16–17-year-olds, and 17.2% from 18–20-year-olds. …”
  15. 67675

    Data_Sheet_1_The association between dietary branched-chain amino acids and the risk of cardiovascular diseases in Chinese patients with type 2 diabetes: A hospital-based case–cont... by Lu Zheng (132726)

    Published 2022
    “…Cases with CVD were 1:1 matched to controls with type 2 diabetes but without CVD by age (±5 years) and sex. A validated 79-item semiquantitative food frequency questionnaire (FFQ) was administered to assess the participants' dietary data. …”
  16. 67676

    Genome representation of the sorghum GCGC collection, obtained from the assignation by STRUCTURE software at a 0.7 threshold (Pritchard et al. 2000) of each sample in K hypothetica... by Claire Billot (85073)

    Published 2013
    “…Each accession on the X-axis is represented by K colours ordered according to a decreasing genome fraction on the Y-axis. At K = 10, Group 1 in orange: C, CB and D from Eastern Asia, Group 2 in light orange: D and B from the Indian subcontinent, Group 3 in light green: D from Eastern Africa, Group 4 in light blue: B and DB from Eastern Africa, Group 5 in dark blue: G and Gma from Western Africa and B from North America, Group 6 in red: D, DC and G from Western Africa, Group 7 in light purple: C from Central and Eastern Africa, Group 8 in dark green: C and GC from Southern Africa, Group 9 in pink: G from Asia and Southern Africa and C from Eastern Africa, and Group 10 in purple: GC, K and KC from Southern Africa.…”
  17. 67677

    A visual depiction of the difference between Log Fold Changes (LFCs), <i>θ</i> defined by Eq (2), and LFCs of CLR transformed amounts, <i>ϑ</i> defined by Eq (4). by Kyle C. McGovern (17420005)

    Published 2023
    “…Still, each of these entities has a negative <i>ϑ</i><sub><i>d</i></sub>, as their LFCs are each less than the mean LFC of all the entities. …”
  18. 67678

    Data Sheet 3_Epidemiology of inflammatory bowel disease-associated anemia in children and adolescents from 1990 to 2021: a global, regional analysis from the Global Burden of Disea... by Chenjing Xu (12109035)

    Published 2025
    “…</p>Conclusion<p>The ASPR of IBD-associated anemia in children and adolescents increased from 2005 to 2010 and then decreased after reaching a peak in 2010. In the future, IBD-associated anemia will continue to pose a significant public health problem.…”
  19. 67679

    Data Sheet 1_Epidemiology of inflammatory bowel disease-associated anemia in children and adolescents from 1990 to 2021: a global, regional analysis from the Global Burden of Disea... by Chenjing Xu (12109035)

    Published 2025
    “…</p>Conclusion<p>The ASPR of IBD-associated anemia in children and adolescents increased from 2005 to 2010 and then decreased after reaching a peak in 2010. In the future, IBD-associated anemia will continue to pose a significant public health problem.…”
  20. 67680

    Data Sheet 2_Epidemiology of inflammatory bowel disease-associated anemia in children and adolescents from 1990 to 2021: a global, regional analysis from the Global Burden of Disea... by Chenjing Xu (12109035)

    Published 2025
    “…</p>Conclusion<p>The ASPR of IBD-associated anemia in children and adolescents increased from 2005 to 2010 and then decreased after reaching a peak in 2010. In the future, IBD-associated anemia will continue to pose a significant public health problem.…”